Last updated on January 2020

A Study of ASP2215 (Gilteritinib) by Itself ASP2215 Combined With Azacitidine or Azacitidine by Itself to Treat Adult Patients Who Have Recently Been Diagnosed With Acute Myeloid Leukemia With a FLT3 Gene Mutation and Who Cannot Receive Standard Chemotherapy


Find a site near you

Start Over

Site JP81003

Yokohama, Japan
0.84miles
  Connect »

Site JP81032

Yokohama, Japan
6.65miles
  Connect »